As many Type 2 diabetics are overweight or obese, prescription weight-loss drugs like phentermine provide an important treatment option to help diabetics control their condition by managing their weight. Phentermine works both as a stimulant and an appetite suppressant. At the time of publication, ...Read More »
Be Informed
Qnexa is a combination of two older drugs: the amphetamine phentermine , which is approved for short-term weight loss, and topiramate ..... antimigraine drug sold by Johnson & Johnson as Topamax. Phentermine helps suppress appetite, while topiramate is supposed to
took a high dose of the two drugs, phentermine and topiramate, experienced a 5 percent ..... journal the Lancet. Drug combination Phentermine is approved by the Food and Drug Administration ..... one of three treatments: a placebo, phentermine and topiramate, or a higher dose of
consumed. It is the only prescription weight loss drug available for long-term use, though appetite-suppressing drugs like phentermine are approved for short-term use. Orlistat has never been popular, in part due to unpleasant side effects, including
Currently there is just one prescription drug on the market for long-term weight loss: Roche's Xenical, which is not widely used. Several other generic drugs are approved for short-term weight loss, including phentermine .
Be Entertained
Qnexa is a combination of two older drugs: the amphetamine phentermine , which is approved for short-term weight loss, and topiramate ..... antimigraine drug sold by Johnson & Johnson as Topamax. Phentermine helps suppress appetite, while topiramate is supposed to
Qnexa is a combination of two older drugs: the amphetamine phentermine , which is approved for short-term weight loss, and topiramate ..... convulsant drug sold by Johnson & Johnson as Topamax. Phentermine helps suppress appetite, while topiramate is believed to
researchers report. The drug, which will be called Qnexa if it reaches the market, is a combination of the appetite suppressant phentermine and the anti-seizure drug topiramate. So far, it's had a bumpy road to approval. Last year, the Food and Drug Administration
animal studies. A few days later, it shot down Vivus' Qnexa, which also combined two known drugs -- appetite suppressant phentermine and anti-seizure drug topiramate, and asked for more data on its heart risks. Both moves followed negative FDA advisory